Form D · Pharmaceuticals
Synchronicity Pharma, Inc.
San Jose, CA · CIK 0001593318
Offering snapshot reported Jan 25, 2022 · SEC filing
- Reported sold
- $1.6M Offering amount: $3M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 11, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2022 | Initial | $1,600,000 | No comparison | 3 | SEC filing |
| Oct 24, 2019 | Initial | $5,953,344 | No comparison | 3 | SEC filing |
| Jun 20, 2018 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
| Feb 19, 2016 | Initial | $29,727,145 | No comparison | 2 | SEC filing |
| Oct 7, 2015 | Amendment | $9,100,000 | $1,300,000vs Jun 1, 2015 | 2 | SEC filing |
| Jun 1, 2015 | Amendment | $7,800,000 | $2,800,000vs Jan 8, 2015 | 2 | SEC filing |
| Jan 8, 2015 | Amendment | $5,000,000 | $4,693,169vs Jul 25, 2014 | 2 | SEC filing |
| Jul 25, 2014 | Initial | $306,831 | No comparison | 2 | SEC filing |
| Dec 3, 2013 | Initial | $14,796,231 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-430716
Source: Form D, filed Jan 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Glenn Batchelder | Director, Executive |
| Ross Bersot | Director, Executive |
| Frederick B Craves | Director |
| Hoyoung Huh | Director |
| Paul Humphries | Executive |
| Blair Jackson | Director |
| Steve Kay | Director |
| Shuichi Kurosaki | Executive |
| Shu Kurosaki | Executive |
| Peter Schultz | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1416 Saratoga Avenue #133
San Jose, CA, 95129
San Jose, CA, 95129